Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap

Status Completed

Clinical Trial Summary

This study will compare by swept-source optical coherence tomography (SS-OCT) the retinal morphology after inverted internal limiting membrane (I-ILM) flap vitreoretinal surgery for medium-to-large macular holes using infracyanine green (IFCG) vs brilliant blue G (BBG) dyeing. It is a single-center prospective, randomized study. One group of patients will undergo I-ILM vitrectomy with IFCG staining, the other vitrectomy with BBG staining. Postoperative twelve-month corrected distance visual acuity, macular hole closure rate, and SS-OCT parameters will be compared and statistically analyzed. The aim of the study is to verify if these parameters can be negatively affected by toxicity related to the use of one of the two dyes.

Clinical Trial Description

The purpose of this study is to compare by swept-source optical coherence tomography (SS-OCT) the retinal morphology after inverted internal limiting membrane flap (I-ILM) surgery for medium-to-large macular holes (FTMHs) using infracyanine green (IFCG) vs brilliant blue G (BBG). This prospective randomized study include 40 eyes with ≥ 400 µ idiopathic FTMH undergoing IFCG or BBG-stained I-ILM technique. Just before surgery, randomization is performed using the sealed-envelope technique, based on the patients' surgical chart number. The random allocation sequence is generated by the trial statistician pulling 41 standard-sized pieces of paper out of a hat. Twenty pieces of paper are marked with the Letter I, for IFCG, and 21 with the Letter B, for BBG. The trial statistician then sequentially puts each piece of paper into 41 sealed opaque envelopes. These envelopes are numbered 1 to 41 and given to the surgeons. Patients are numbered randomly from 1 to 41 based on a surgical chart number related to the baseline testing session and intervention period. Clinical data collection and measurement of outcome variables are performed by personnel masked to the randomization process and not been directly involved in the patients' surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03946267
Study type	Interventional
Source	Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Contact
Status	Completed
Phase	N/A
Start date	January 9, 2018
Completion date	August 23, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Completed	`NCT04535622` - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery	N/A
Completed	`NCT03572725` - Air Tamponade and Non-supine Positioning in Macular Hole Surgery.	N/A
Completed	`NCT01471912` - Elongation of Foveal Tissue After Macular Hole Surgery	N/A
Completed	`NCT03646695` - ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study	N/A
Completed	`NCT06323902` - Autologous Platelet-rich Plasma as a Treatment for Macular Holes
Completed	`NCT01974310` - Postoperative Positioning After Surgery for Macular Holes	N/A
Completed	`NCT00537992` - Blue-Blocking IOLs in Combined Surgery	N/A
Completed	`NCT05171621` - Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery
Recruiting	`NCT06000111` - Duration of Face Down Positioning for Full-Thickness Macular Hole Repair	N/A
Recruiting	`NCT04135638` - Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison	N/A
Completed	`NCT03525899` - Macular Hole After Diabetic Vitrectomy
Completed	`NCT03917602` - Human Amniotic Membrane Plug for Large Macular Holes	N/A
Completed	`NCT04527848` - Comparison of Two Intraocular Gas Injection Techniques in Macula Hole Surgery	Phase 4
Recruiting	`NCT04116892` - Comparative Analysis of Large Macular Hole Surgeries	N/A
Completed	`NCT01229657` - Evaluation of Anatomic and Visual Outcomes of Initially Closed Macular Holes	N/A
Completed	`NCT01306487` - Observation of Recovery of Foveal Cone Microstructures After Macular Hole Surgery	N/A
Completed	`NCT01381965` - Foveal Cone Outer Segment Resumption to Predict Visual Recovery After Macular Hole Surgery	N/A
Completed	`NCT03174639` - High Myopia Macular Hole and Retinal Detachment Treated With Double ILM Flaps	N/A
Recruiting	`NCT05083650` - Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms